The Valley Desk

NCT03229200 · Interventional trial

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Overall registry status Active not recruiting

Phase 4

Conditions Graft Vs Host Disease, Leukemia, B-cell, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov